Join us on December 11, 2024, for an exclusive look into cutting-edge biomanufacturing: "Faster, Smaller, Smarter: Intelligent Manufacturing of mRNA through Process Analytical Technologies."
In partnership with MIT, ReciBioPharm (RBP) is pioneering a revolutionary approach to mRNA manufacturing. This digital transformation accelerates development timelines from a year to mere months, while compressing the entire cGMP manufacturing process into just one day. Through robust data and advanced Process Analytical Technologies (PAT), RBP moves beyond traditional, limiting batch methods to a real-time, predictive, continuous manufacturing model.
Gain insights into PAT’s impact on enhancing manufacturing efficiency and speed and discover how integrated data and automation can streamline operations, reduce time-to-market, and ensure product quality.
What You’ll Learn:
- Key benefits of Process Analytical Technologies (PAT)
- How continuous manufacturing drives efficiency
- The power of an integrated digital infrastructure
Speakers: Dr. Aaron Cowley, CSO and Dr. Edita Botonjic-Sehic, Senior Director of Process Sciences